Literature DB >> 8172267

Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders.

S S Hayreh1, M B Zimmerman, P Podhajsky, W L Alward.   

Abstract

We measured 24-hour ambulatory blood pressure monitoring and diurnal curve of the intraocular pressure in 166 white patients with anterior ischemic optic neuropathy, normal-tension glaucoma, primary open-angle glaucoma, and other optic nerve head disorders. Hourly average blood pressure data analyses showed a significant (P < .0001) decrease in mean systolic (26%) and diastolic (33%) blood pressure measurements at night. A significantly (P = .0028) lower nighttime mean diastolic blood pressure and a significantly (P = .0044) greater mean percentage decrease in diastolic blood pressure were noted in normal-tension glaucoma than in anterior ischemic optic neuropathy. Patients with arterial hypertension taking oral hypotensive therapy showed a significant association between progressive visual field deterioration and nocturnal hypotension, particularly in anterior ischemic optic neuropathy. Intraocular pressure showed no significant correlation with visual field deterioration in any of these conditions. Our findings suggest that nocturnal hypotension, in the presence of other vascular risk factors, may reduce the optic nerve head blood flow below a critical level, and thereby may play a role in the pathogenesis of anterior ischemic optic neuropathy and glaucomatous optic neuropathy; that is, nocturnal hypotension may be the final insult in a multifactorial situation. The same mechanisms may be true of a number of other ocular ischemic disorders. This finding opens a new dimension in the understanding and management of these visually disabling diseases.

Entities:  

Mesh:

Year:  1994        PMID: 8172267     DOI: 10.1016/s0002-9394(14)70067-4

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  145 in total

1.  Endothelial nitric oxide synthase gene polymorphisms in non-arteritic anterior ischemic optic neuropathy.

Authors:  Tsutomu Sakai; Keigo Shikishima; Masato Matsushima; Kenji Kitahara
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-02       Impact factor: 3.117

2.  Non-arteritic anterior ischemic optic neuropathy versus cerebral ischemic stroke.

Authors:  Sohan Singh Hayreh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-04-21       Impact factor: 3.117

Review 3.  A biomechanical paradigm for axonal insult within the optic nerve head in aging and glaucoma.

Authors:  Claude F Burgoyne
Journal:  Exp Eye Res       Date:  2010-09-16       Impact factor: 3.467

4.  Natural history of visual outcome in central retinal vein occlusion.

Authors:  Sohan Singh Hayreh; Patricia A Podhajsky; M Bridget Zimmerman
Journal:  Ophthalmology       Date:  2010-08-17       Impact factor: 12.079

5.  Thinning of the inner and outer retinal layers, including the ganglion cell layer and photoreceptor layers, in obstructive sleep apnea and hypopnea syndrome unrelated to the disease severity.

Authors:  Soner Guven; Deniz Kilic; Omer Faruk Bolatturk
Journal:  Int Ophthalmol       Date:  2021-06-25       Impact factor: 2.031

6.  Role of retinal hypoxia in diabetic macular edema: a new concept.

Authors:  Sohan Singh Hayreh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-09-18       Impact factor: 3.117

Review 7.  Treatment of nonarteritic anterior ischemic optic neuropathy.

Authors:  Edward J Atkins; Beau B Bruce; Nancy J Newman; Valérie Biousse
Journal:  Surv Ophthalmol       Date:  2010 Jan-Feb       Impact factor: 6.048

Review 8.  [Anterior ischemic optic neuropathy: Etiology, pathogenetic mechanisms and therapy].

Authors:  R Unsöld
Journal:  Ophthalmologe       Date:  2008-09       Impact factor: 1.059

9.  Glaucoma and vasospasm.

Authors:  D C Broadway; S M Drance
Journal:  Br J Ophthalmol       Date:  1998-08       Impact factor: 4.638

10.  Retinal blood flow measurements and neuroretinal rim damage in glaucoma.

Authors:  J F J Logan; S J A Rankin; A J Jackson
Journal:  Br J Ophthalmol       Date:  2004-08       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.